A multicentered , randomized , open study on efficacy and safety of Meifute ® antifungal solution of optimal application time in moccasin-type tinea pedis
暂无分享,去创建一个
Xiaoping Hu | P. Feng | Yue Zheng | W. Lai | Yan Gao | Xuhua Tang | Z. Gong | Xiuqin Dong | M. Gu | Xiaoyuan Xie | Song-chao Yin | Qinghua Guo | Yumei Liu | Wen-liang Yang | Fang Yang
[1] A. M. Reis,et al. Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High‐Complexity Hospital , 2016, Journal of clinical pharmacology.
[2] T. Vlahovic. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis. , 2016, Journal of drugs in dermatology : JDD.
[3] Y. Tsunemi. Oral Antifungal Drugs in the Treatment of Dermatomycosis. , 2016, Medical mycology journal.
[4] Y. Ran,et al. Administration of Oral Itraconazole Capsule with Whole Milk Shows Enhanced Efficacy As Supported by Scanning Electron Microscopy in a Child with Tinea Capitis Due to Microsporum canis , 2015, Pediatric dermatology.
[5] A. Fleischer,et al. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. , 2015, Journal of drugs in dermatology : JDD.
[6] M. Ilkit,et al. Tinea pedis: The etiology and global epidemiology of a common fungal infection , 2015, Critical reviews in microbiology.
[7] Y. Zou,et al. Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study , 2015, Clinical Drug Investigation.
[8] B. Shah,et al. Development of self emulsifying drug delivery system of itraconazole for oral delivery: formulation and pharmacokinetic consideration , 2015, Journal of Pharmaceutical Investigation.
[9] Y. Ran,et al. Successful treatment of oral itraconazole for infantile hemangiomas: A case series , 2015, The Journal of dermatology.
[10] J. Ely,et al. Diagnosis and management of tinea infections. , 2014, American family physician.
[11] B. Ahishali,et al. Ultrastructural Alterations In The Epidermis Of Patients With Tinea Pedis , 2009 .
[12] T. Kurth,et al. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. , 2007, The American journal of medicine.
[13] J. Castellsagué,et al. Risk of serious skin disorders among users of oral antifungals: a population-based study , 2002, BMC dermatology.
[14] K. Katsuoka,et al. Bifonazole (Mycospor® cream) in the treatment of moccasin‐type tinea pedis. Comparison between combination therapy of bifonazole cream +10% urea ointment (Urepearl®) and occlusive dressing therapy with the same agents , 2000, Mycoses.
[15] S. Nishiyama,et al. Clinical evaluation of bifonazole for moccasin‐type tinea pedis , 1997, Mycoses.
[16] R. Savin. Terbinafine (Lamisil) versus griseofulvin in moccasin type tinea pedis , 1990 .
[17] D. Greer. Topical treatment for moccasin-type tinea pedis. , 1987, Journal of the American Academy of Dermatology.